Donoghue Forlines LLC Seagen Inc. Transaction History

Donoghue Forlines LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $826,620 - $1.11 Million	-5,798 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $29,202 - $34,813	205 Added 3.67%	5,798 $985,000
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $33,634 - $40,113	249 Added 4.66%	5,593 $883,000
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $169,687 - $235,447	1,234 Added 30.02%	5,344 $742,000
Q4 2020 Feb 09, 2021	BUY	$164.63 - $211.93 $676,629 - $871,032	4,110 New	4,110 $720,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

Stay updated on Donoghue Forlines LLC with notifications on news.